Crossref

1. Dynamics of HCV epidemiology in Aydin province of Turkey and the associated factors

- Sevin Kirdar

- Neriman Aydin

- Yasin Tiryaki

- Bulent Ertugrul

- Adil Coskun

- Mehmet Bilgen

2.

3. An update on hepatitis C virus genotype distribution in Jordan: a 12-year retrospective study from a tertiary care teaching hospital in Amman

- Malik Sallam

- Rawan Batarseh

- Anas Natsheh

- Jumana Abbadi

- Esraa Al-Fraihat

- Alaa’ Yaseen

- Doaa Kaddomi

- Nadia Khamees

- Azmi Mahafzah

- Gülşen Özkaya Şahin

4. Unique situation of hepatocellular carcinoma in Egypt: A review of epidemiology and control measures

- Reem Ezzat

- Mohamed Eltabbakh

- Mohamed El Kassas

5. Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center

- Ridha H Alkhalifah

- Mousa J Alhaddad

- Ali T Alhashem

- Hussain Alwesaibi

- Abdullah A AlKhalaf

- Abdullah Albin Saad

- Mohammed Almattar

- Makarem A Alkhalaf

- Habib Alramadhan

- Mohammad Albaggal

6.

7.

8. Distribution of Hepatitis C Virus Genotypes in Rasht, Capital City of Guilan Province, Northern Part of Iran

- Dariush Naghipour-Khalkhaliani

- Daryoush Behzadpour

- Seyed Dawood Mousavi Nasab

9. Efficacy and Safety of Generic Sofosbuvir/Ledipasvir Fixed-Dose Combination in Iranian Patients with Chronic Hepatitis C Virus Infection

- Heidar Sharafi

- Mehri Nikbin

- Seyed Hoda Alavian

- Bita Behnava

- Seyed Moayed Alavian

10. High prevalence of occult hepatitis C virus infection in injection drug users with HIV infection

- Tahereh Donyavi

- Farah Bokharaei-Salim

- Khadijeh Khanaliha

- Maryam Sheikh

- Mohammad-Navid Bastani

- Najmeh Moradi

- Roghayeh Babaei

- Zahra Habib

- Atousa Fakhim

- Maryam Esghaei

11. HCV Genotype Distribution Among People Who Inject Drug in Turkey: Findings from Multicenter and Cross-Sectional Study

- Nesrin Dilbaz

- Murat Kuloğlu

- Ekrem Cuneyt Evren

- Salih Cihat Paltun

- Rabia Bilici

- Cemal Onur Noyan

- Burak Kulaksizoglu

- Vahap Karabulut

- Gokhan Umut

- Basak Unubol

- Enver Ucbilek

12. Changes in Hepatitis C Virus Genotype Distribution in Chronic Hepatitis C Infection Patients

- Mehmet Burak Selek

- Orhan Baylan

- Ergenekon Karagöz

- Mustafa Özyurt

13.

14. Determination of hepatitis C virus subtype prevalent in Sindh, Pakistan: a phylogenetic analysis

- Saba Farooq

- Sirmast Faiz

- Atia-tul Wahab

- M. Iqbal Choudhary

15. Risk factors and outcome of hepatitis C infection among patients in a secondary care hospital: A 5-year retrospective study

- Mohan B. Sannathimmappa

- Latifa Zehri

- Ayat A. M. Al Zadjali

- Halima M. A. Albalushi

- Buthaina A. A. H. Al Saadi

- Rajeev Aravindakshan

- Elham S. Al-Risi

- Saleema Al-Maqbali

- Vinod Nambiar

16. Prevalence and genetic diversity of HCV among HIV-1 infected individuals living in Ahvaz, Iran

- Ali Teimoori

- Saeedeh Ebrahimi

- Narges Keshtkar

- Soheila Khaghani

- Shokrollah Salmanzadeh

- Shokouh Ghafari

17. Molecular Tracing of Hepatitis C Virus Genotype 1 Isolates in Iran: A NS5B Phylogenetic Analysis with Systematic Review

- Khashayar Hesamizadeh

- Seyed Moayed Alavian

- Azar Najafi Tireh Shabankareh

- Heidar Sharafi

18. Seroprevalence and Genotypic Distribution Patterns of Hepatitis C Virus among Infected Patients from Sulaimaniyah Province: Iraq

- Awat Hasan

- Zhian Ramzi

- Mohammed Alshekhani

19. Overview of hepatitis C infection, molecular biology, and new treatment

- Ali A. Rabaan

- Shamsah H. Al-Ahmed

- Ali M. Bazzi

- Wadha A. Alfouzan

- Shahab A. Alsuliman

- Fatimah A. Aldrazi

- Shafiul Haque

20. Hepatitis B and Hepatitis C in Patients with Inherited Disorders of Hemoglobin in Sistan and Baluchistan Province, Iran

- Soheila Khosravi

- Heidar Sharafi

- Esmaeil Sanei Moghadam

- Fariba Heidari

- Mahmod Naibzadeh

- Seyed Moayed Alavian

21. Safety and efficacy of combined sofosbuvir/daclatasvir treatment of children and adolescents with chronic hepatitis C Genotype 4

- Tawhida Y. Abdel Ghaffar

- Suzan El Naghi

- Manal Abdel Gawad

- Sarah Helmy

- Aisha Abdel Ghaffar

- Medhat Yousef

- Mohamad Moafy

22. Seroprevalence of Hepatitis B and Hepatitis C in Inpatients for Alcohol and Drug Addiction Treatment in the Psychiatry Clinic of a Private Hospital

- Serpil MIZRAKÇI

- Mukerrem GUVEN

- Sevil ALKAN

23. Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study

- Mohammad Tasavon Gholamhoseini

- Heidar Sharafi

- Helena HL Borba

- Seyed Moayed Alavian

- Asma Sabermahani

- Behzad Hajarizadeh

24. Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis

- Hossein Ghaderi-Zefrehi

- Heidar Sharafi

- Farzin Sadeghi

- Mohammad Gholami-Fesharaki

- Alireza Farasat

- Fatemeh Jahanpeyma

- Seyed Moayed Alavian

25. Retreatment of Egyptian Chronic Hepatitis C Patients Not Responding to Pegylated Interferon and Ribavirin Dual Therapy

- Mohamed Aboushady

- Ahmed Alwassief

- Mohamed Abdelrazik

- Dina Ziada

- Hossam Shahba

- Amr Elmestikawy

- Ashraf Elbahrawy

26. Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country

- Marcarious M. Tantuoyir

- Muhammed Camara

- Marjan Sohrabi

- SeyedAhmad SeyedAlinaghi

- Zahra Ahmadinejad

27. The Prevalence of Hepatitis C Virus Genotypes in Mazandaran Province, Iran

- Parisa Ebrahimzadeh

- Mohammadreza Haghshenas

- Farhang Babamahmoodi

28. APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysis

- Magdy Amin El Serafy

- Abdel Meguid Kassem

- Heba Omar

- Mohammad Shaaban Mahfouz

- Maissa El Said EL Raziky

29. Elimination of hepatitis C in Egypt: unprecedented achievement despite challenges

- AbdulRahman A Saied

- Zeinab Kamal

- Ali B Roomi

- Asmaa A Metwally

30. Cardiac echoparameters (geometry and dimensions), interleukin 6, and anthropometric measurements in Egyptian adolescents with hepatitis C and hepatocellular carcinoma

- Waleed M. Elguindy

- Waleed M. Serag

31. Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank

- Heidar Sharafi

- Saeideh Maleki

- Seyed Moayed Alavian

32. Sub-genotypes of hepatitis C virus in the Middle East and North Africa: Patterns of distribution and temporal changes

- Rabaa Y. Athamneh

- Rawan Abudalo

- Malik Sallam

- Abdelrahim Alqudah

- Hasan Alquran

- Kawther Faisal Amawi

- Hashem A. Abu-Harirah

33. Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank

- Heidar Sharafi

- Saman Ghalamkari

- Alireza Hassanshahi

- Seyed Moayed Alavian

34. Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients

- Rasoul Baharlou

- Bizhan Romani

- Seyed Jalal Kiani

- Kaveh Sadeghi

- Enayatollah Shadmand

- Hadi Fazel

- Farid Azizi Jalilian

- Ebrahim Kord

- Sajad Yaghoubi

- Yousef Nikmanesh

- Abbas Ahmadi Vasmehjani

35. The prevalence of hepatitis C virus genotypes and factors associated with cirrhosis, fatty liver, and viral load: A registry‐based cross‐sectional cohort study in Western Iran during 1999–2023

- Babak Sayad

- Arezoo Bozorgomid

- Nazanin Sayad

- Marya Azhdari

- Maryam Bahadori

- Shahab Rezaeian

- Maryam Gholizadeh

36. Distribution of Hepatitis C Virus Genotypes and Related Risk Factors Among Iranian Blood Donors: A Penalized Logistic Regression

- Fahimeh Ranjbar Kermani

- Sedigheh Amini-Kafiabad

- Kamran Mousavi Hosseini

- Mahtab Maghsudlu

- Zohreh Sharifi

- Mohammad Ali Mansournia

37. A Systematic Review on the Evolution of Natural Mutation-dependent Antiviral Drug Resistance in Hepatitis C Virus (HCV) Genotypes Prevalent in Saudi Arabia: A Genomic and Therapeutic Perspective

- Mohammad Asrar Izhari

38. Impact of IL28B gene polymorphism on efficacy and safety of direct acting antivirals in hepatitis C Egyptian patients

- Abdel-Hameed Ibrahim Mohamed Ebid

- Ossama Ashraf Ahmed

- Sara Hassan Agwa

- Sara Mohamed Abdel-Motaleb

- Radwa Samir Hagag

39. Effectiveness of Ledipasvir-Sofosbuvir 12 Weeks After Hepatitis C Virus Genotype 1 Infection and the Factors Associated With Sustained Virologic Response: A Retrospective Study

- Ismaeel A Alshoaibi

- Abdullah Al-Gamli

- Mohammed Abdullah

- Basheer Abdo

- Khaled H Alzanen

- Mohammed Alhakamy

- Mamoon Al-Namer

- Faisal Ahmed

- Munther Tamesh

- Wadhah Mahdi

- Zeyad Abdo

- Marwa Mohammed

40. Systematic overview of hepatitis C infection in the Middle East and North Africa

- Karima Chaabna

- Sohaila Cheema

- Amit Abraham

- Hekmat Alrouh

- Albert B Lowenfels

- Patrick Maisonneuve

- Ravinder Mamtani

41. Subgenotyping and genetic variability of hepatitis C virus in Palestine

- Sahar Rayan Da’as

- Maysa Azzeh

- Jason Blackard

42. The Role of Polymorphisms Near IFNL3 Gene as Predictors of Residual HCV RNA in Buffy Coat after Successful Antiviral Therapy

- Seyyed Mohammad Miri

- Heidar Sharafi

- Ali Pouryasin

- Bita Behnava

- Maryam Keshvari

- Shima Salimi

- Pegah Karimi Elizee

- Seyed Moayed Alavian